Abstract
Antibiotic-resistant bacteria continue to play an important role in human health and disease. Inventive strategies are necessary to develop new therapeutic leads to challenge drug-resistance problems. From this perception, new quinoline hybrids bearing bioactive pharmacophores were synthesized. The newly synthesized compounds were evaluated for their in vitro antibacterial activity against nine bacterial pathogenic strains. The results revealed that most compounds exhibited good antibacterial activities. Seven compounds (2b, 3b, 4, 6, 8b, and 9c,d) displayed enhanced activity against methicillin-resistant Staphylococcus aureus compared to ampicillin. These compounds were subjected to an in vitro S. aureus DNA gyrase ATPase inhibition study, which revealed that compounds 8b, 9c, and 9d showed the highest inhibitory activity with IC50 values of 1.89, 2.73, and 2.14 μM, respectively, comparable to novobiocin (IC50 , 1.636 μM). Compounds 2a-c, 3a, 7c, 9c,d, and 10a,b revealed half the potency of levofloxacin in inhibiting the growth of Pseudomonas aeruginosa. As an attempt to rationalize the observed antibacterial activity for the most active compounds 8b, 9c, and 9d, molecular docking in the ATP binding site of S. aureus gyrase B ...Continue Reading
References
Mar 6, 1992·Journal of Medicinal Chemistry·D T ConnorC D Wright
Dec 11, 1999·Nucleic Acids Research·H M BermanP E Bourne
Mar 21, 2002·Il Farmaco·Sandra PirasGiuseppe Paglietti
Jun 23, 2007·Current Medicinal Chemistry·John B BremnerSiritron Samosorn
Mar 31, 2010·Bioorganic & Medicinal Chemistry·Fatmah A M Al-OmaryHussein I El-Subbagh
Mar 31, 2010·Bioorganic & Medicinal Chemistry·Nafees AhmedKamlesh K Bhutani
May 11, 2010·European Journal of Medicinal Chemistry·Balladka Kunhanna SarojiniHanumanthappa Manjunatha
Jul 8, 2010·European Journal of Medicinal Chemistry·Samir BondockMohamed A Metwally
Jan 29, 2011·The Lancet Infectious Diseases·Marisa H MiceliSamuel A Lee
Sep 10, 2011·Applied Microbiology and Biotechnology·Frédéric CollinAnthony Maxwell
Jan 24, 2012·Bioorganic & Medicinal Chemistry·P ZoumpoulakisA Pitsas
Mar 19, 2013·BMC Research Notes·Shyam Kumar MishraBharat Mani Pokhrel
Dec 24, 2013·Bioorganic & Medicinal Chemistry Letters·Chao ChenMichael J Kelso
May 27, 2014·Bioorganic & Medicinal Chemistry Letters·N C DesaiA R Trivedi
Dec 3, 2014·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Rangappa S Keri, Siddappa A Patil
Dec 30, 2014·European Journal of Medicinal Chemistry·Stéphanie VandekerckhoveMatthias D'hooghe
Jan 16, 2015·Bioorganic Chemistry·Said A H El-FekyHamdy Kh Thabet
Jan 17, 2015·Bioorganic & Medicinal Chemistry·Stéphanie Vandekerckhove, Matthias D'hooghe
Jul 1, 2015·Journal of Medicinal Chemistry·Nace ZidarDanijel Kikelj
Aug 22, 2015·European Journal of Medicinal Chemistry·Virginia SpanòPaola Barraja
Oct 16, 2015·Journal of Medicinal Chemistry·Jing ZhangRoland E Dolle
May 24, 2016·Bioorganic & Medicinal Chemistry Letters·Xing ZhangRobert J Linhardt
Nov 9, 2017·European Journal of Medicinal Chemistry·Mohamed F El ShehryYousry A Ammar
Jan 9, 2018·European Journal of Medicinal Chemistry·M Madhu SekharT Vijaya
Mar 31, 2018·Bioorganic Chemistry·Ibrahim ChaabanHisham A Nematalla
May 31, 2018·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Nazar TrotskoAnna Malm
Jun 25, 2018·European Journal of Medicinal Chemistry·Akash BasakRobert W Huigens
Feb 19, 2019·European Journal of Medicinal Chemistry·Davide Benedetto TizNace Zidar